Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
PDCD4 limits prooncogenic neuregulin-ErbB signaling.
Cell Mol Life Sci. 2021 Feb;78(4):1799-1815. doi: 10.1007/s00018-020-03617-5. Epub 2020 Aug 17.
Cell Mol Life Sci. 2021.
PMID: 32804243
Free PMC article.
Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer.
Noblejas-López MDM, Nieto-Jimenez C, Burgos M, Gómez-Juárez M, Montero JC, Esparís-Ogando A, Pandiella A, Galán-Moya EM, Ocaña A.
Noblejas-López MDM, et al.
J Exp Clin Cancer Res. 2019 Aug 30;38(1):383. doi: 10.1186/s13046-019-1387-5.
J Exp Clin Cancer Res. 2019.
PMID: 31470872
Free PMC article.
Item in Clipboard
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer.
Montero JC, Calvo-Jiménez E, Del Carmen S, Abad M, Ocaña A, Pandiella A.
Montero JC, et al.
J Exp Clin Cancer Res. 2022 Mar 22;41(1):106. doi: 10.1186/s13046-022-02330-4.
J Exp Clin Cancer Res. 2022.
PMID: 35317825
Free PMC article.
Item in Clipboard
Cite
Cite